5:46 PM
 | 
May 27, 2008
 |  BC Extra  |  Company News

Bristol-Myers, sanofi withdraw DuoPlavin MAA

EMEA said Bristol-Myers (NYSE:BMY) and sanofi-aventis (Euronext:SAN; NYSE:SNY) withdrew an MAA for DuoPlavin clopidogrel/acetylsalicylic acid to prevent...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >